1734
vs
T
Taiwan Weighted Index
1734
Over the past 12 months, Sinphar Pharmaceutical Co Ltd has underperformed Taiwan Weighted Index, delivering a return of -4% compared to the Taiwan Weighted Index's +52% growth.
Stocks Performance
1734 vs Taiwan Weighted Index
Performance Gap
1734 vs Taiwan Weighted Index
Performance By Year
1734 vs Taiwan Weighted Index
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Sinphar Pharmaceutical Co Ltd
Glance View
Sinphar Pharmaceutical Co. Ltd. is engaged in the manufacturing, processing and trading of various western medicines, therapeutic drugs, medicated cosmetics, nutriment, health care foods, and cleaning liquid. The company is headquartered in Dongshan, Yilan. The company went IPO on 2000-10-17. The firm is also engaged in the sales of functional food products. The Company’s principal products include ointment, gel, cream, hard and soft capsules, sugar-coated tablets, film-coated tablets, suppositories, powders and granules, lozenges, soft candies, oral and topical liquid medicines, injections, dry medicated powers, functional food products, medical equipment and cosmetics. The firm mainly sells its products to hospitals, drug stores, clinics, dealers and distributors. Its primary markets are located in Taiwan and overseas countries.
